CAU
ACH

Caxton Associates (UK)’s Accendra Health ACH Stock Holding History

Caxton Associates (UK)’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-151,933
Closed -$1.38M – 880
2025
Q2 		$1.38M Buy
+151,933
New +$1.12M 0.04% 255

Other funds holding ACH

CCM
Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Caxton Associates (UK)'s ACH Position: Q3 2025 in Review

Caxton Associates (UK) sold out of Accendra Health (ACH) in Q3 2025, closing a stake of 151,933 shares — an estimated $1.38M sold.

Caxton Associates (UK) first reported a position in ACH in Q2 2025 and held it in 1 quarter. The position peaked at $1.38M in Q2 2025. 202 funds tracked by Wall St. Rank hold ACH as of Q3 2025.

  • Caxton Associates (UK) reported no remaining Accendra Health position as of Q3 2025 after selling out during the quarter.
  • Caxton Associates (UK) sold 151,933 Accendra Health shares in Q3 2025, an estimated $1.38M.
  • Caxton Associates (UK) first reported a position in Accendra Health in Q2 2025 and held it in 1 quarter.
  • Caxton Associates (UK)'s Accendra Health position peaked at $1.38M in Q2 2025.
  • 202 funds tracked by Wall St. Rank held Accendra Health as of Q3 2025.

Based on Caxton Associates (UK)'s 13F filing for Q3 2025, filed 17 Nov 2025.